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Abstract 
Psychopathy and metacognitive difficulties have been associated with the occurrence of violence 
in schizophrenia. However, evidence suggests that non-schizophrenic psychopaths match or even 
outperform healthy controls on tests of metacognition. We hypothesize that the metacognitive 
difficulties associated with schizophrenia may be ameliorated by co-morbid psychopathy. To this 
end, metacognition (using the Metacognition Assessment Scale-Abbreviated (MAS-A)) and 
psychopathy (using the Hare Psychopathy Checklist-Revised (PCL-R)) are assessed in 79 
patients with schizophrenia with a history of criminal offending. Piece-wise regression reveals 
that the association between metacognition and psychopathy changes from a negative to a 
positive association at a breakpoint corresponding to a score of 24 on the PCL-R. This score is 
within the range of the cut-off point used for the diagnosis of psychopathy in Europe, which 
corresponds to a score of 26 on the PCL-R. The patients scoring above 24 on the PCL-R 
demonstrated better overall metacognitive abilities, suggesting that these patients constitute a 
specific group in which schizophrenia has an attenuated impairing effect on metacognition. 
However, this effect was absent for the Mastery subscale of the MAS-A, which refers to the 
ability to use one’s own mental states to solve social and psychological dilemmas. Our results 
suggest that the relative preservation of metacognitive abilities in schizophrenic patients with 
extreme levels of psychopathy may contribute to their offending behavior as it may enable them 
to understand how to manipulate and extort their victims. However, enhancing the Mastery 
domain of metacognition in these patients may attenuate this offending behavior.  
 
Keywords: aggression, co-morbidity, violence, piecewise regression, Theory of mind 
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Lay summary 
The study examined psychopathic traits and metacognition (the ability to think about thinking) in 
schizophrenia patients with a history of criminal offending. The study suggests that difficulties in 
metacognition are less pronounced in patients with high psychopathy scores.   
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Introduction 
There is a well-established relationship between schizophrenia and violence. This relationship 
has been associated, among other factors, with co-morbid psychopathy and poor metacognitive 
abilities (Bo, Abu-Akel, Kongerslev, Haahr, & Simonsen, 2011). Specifically, violence in 
schizophrenia has been associated with elevated incidences of psychopathy (Abushua'leh & Abu-
Akel, 2006; Nolan, Volavka, Mohr, & Czobor, 1999; K. Rasmussen & Levander, 1996; 
Tengstrom, Hodgins, Grann, Langstrom, & Kullgren, 2004). In addition, psychopathy level is 
considered a robust discriminator between violent and nonviolent patients with schizophrenia (K 
Rasmussen, Levander, & Sletvold, 1995; Tengstrom et al., 2004), particularly in individuals 
scoring above the threshold for psychopathy on the Hare Psychopathy Checklist-Revised (PCL-
R).  
 
Metacognitive abilities refer to the processes associated with monitoring and controlling one’s 
own cognitive processing as well as the reflections people form about others (or mentalizing) 
(Frith, 2012). These abilities range from discrete acts in which people recognize specific 
cognitive and affective mental states to more synthetic acts in which an array of intentions, 
thoughts, feelings, and connections between events are integrated into larger complex 
representations. Importantly, synthetic forms of metacognition are not specifically what one 
thinks or correctly notices (as commonly assessed with standard socio-cognitive tasks of false 
belief, for example), but is instead whether basic elements of experience are recognized and then 
synthesized into meaningful wholes (Bo, Kongerslev, Dimaggio, Lysaker, & Abu-Akel, 2015; 
Lysaker et al., 2013). As such, metacognitive abilities are essential for social interactions in that 
they supply reasons as to why one carries out a certain act, as well as premises for deciding what 
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is the best course of action to resolve dilemmas encountered in daily interactions. They may also 
act as an inhibitor of violence (R. J. Blair, 1995), particularly given their role in recognizing 
distress in others and responding empathically (Decety & Cowell, 2014). In addition, research 
has demonstrated that metacognitive difficulties (Brune, 2005; Lysaker, Shea, et al., 2010; Tas, 
Brown, Esen-Danaci, Lysaker, & Brune, 2012), particularly those associated with the recognition 
of affective states (Shamay-Tsoory, Harari, Aharon-Peretz, & Levkovitz, 2010), contribute to the 
predisposition of schizophrenia patients to violence (Abu-Akel & Abushua'leh, 2004; Bo, Abu-
Akel, Kongerslev, Haahr, & Bateman, 2014; Bo et al., 2011). Support for this comes from 
studies showing that violent schizophrenia patients have difficulties with empathic reasoning and 
spotting faux pas (unintended socially-awkward acts made because of lack of contextual 
knowledge) (Abu-Akel & Abushua'leh, 2004), as well as with reasoning about the emotion of 
others (Bo et al., 2014; Marsh & Blair, 2008).  
 
In contrast to schizophrenia, research investigating metacognitive abilities in individuals with 
psychopathy has shown that while psychopaths have deficits in empathizing and responding to 
the emotions of others, they nonetheless demonstrate relatively intact understanding of the 
cognitive mental states and perspective of others (J. Blair et al., 1996; Dolan & Fullam, 2004; 
Fertuck et al., 2009; Lyons, Healy, & Bruno, 2013; Richell et al., 2003; Wai & Tiliopoulos, 
2012). For example, Richell et al. (Richell et al., 2003) failed to identify any generalized 
impairment among psychopaths relative to non-psychopaths in the ‘Reading the Mind in the 
Eyes Test’, a task requiring the identification of affective mental states from photographs of the 
eye region. Similarly, Dolan and Fullam (Dolan & Fullam, 2004) observed no significant 
differences in basic social cognition tests between individuals with antisocial personality 
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disorder with and without psychopathy compared with healthy controls. The authors accordingly 
argued that the psychopath’s antisocial behavior may not reflect a failure to take the perspective 
of others, but rather a failure to express concern for others’ suffering. More recently, Lyons and 
colleagues found a significant association between the ability to detect lies and primary 
psychopathy (an aspect of psychopathy that is associated with interpersonal and emotional traits) 
(Lyons et al., 2013). Wai and Tiliopoulos also reported that psychopathy was mainly associated 
with deficits in empathizing with others and relating to their emotions, but not in reasoning about 
their cognitive mental states (Wai & Tiliopoulos, 2012). Similar findings were reported in male 
violent offenders (Seidel et al., 2013) and in psychopathic criminal offenders (Shamay-Tsoory et 
al., 2010). Taken together, the poor emotion recognition and empathic deficits seen in 
psychopaths would be expected to increase the probability of them offending violently. 
Conversely, their intact reasoning abilities about the cognitive mental states of others may 
contribute to their offending behavior as it may enable them to understand how to manipulate 
and extort their victims. Thus the metacognitive profile of the psychopath which emerges from 
these studies is consistent with a defining feature of the condition, that is the ability to deceive 
and manipulate others, and a proclivity toward premeditated or goal directed acts of aggression 
(Glenn & Raine, 2009). 
 
The above discussion indicates that while both individuals with psychopathy and those with 
schizophrenia show an increased tendency toward violence, they nonetheless present with 
contrasting metacognitive abilities. Thus, while psychopaths show intact or even superior 
metacognitive abilities relative to normative values, patients with schizophrenia show 
impairments in these abilities. However, the association between psychopathy and metacognition 
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in patients with schizophrenia is poorly understood, since it is uncommon to assess both aspects 
in the same patients. In order to better understand the nature of their association, in this paper, we 
simultaneously assess psychopathy and metacognitive abilities in forensic patients with 
schizophrenia. Although we expect patients with schizophrenia to show overall metacognitive 
difficulties, we hypothesize that these difficulties may be attenuated at extreme levels of 
psychopathy. This hypothesis is supported by evidence showing an association between the 
heightened levels of psychopathy and the incidence of premeditated violence among patients 
with schizophrenia (Bo, Abu-Akel, Kongerslev, Haahr, & Simonsen, 2013), as such 
transgressions require good cognitive perspective-taking abilities (Abu-Akel & Abushua'leh, 
2004; Bo et al., 2011; Rice, 1997).   
 
Materials and Method 
Participants 
The data of 79 patients meeting the International Classifications of Diseases-10th Revision (IDC-
10) diagnostic criteria for schizophrenia were analysed for the purposes of this study. These 
patients were recruited from forensic psychiatric facilities in Denmark, which provide 
compulsory treatment plans for criminal offenders and include psychosocial, psychological, 
fitness and, if needed, medical plans that are designed for the prevention of criminal recidivism. 
These diagnoses were made by highly experienced psychiatrists who work in the forensic 
psychiatric system in Denmark, and are based on the Structured Clinical Interview for DSM-IV 
Axis I Disorders (SCID-I) (First, Spitzer, Gibbon, & Williams, 2002) and the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN) (Wing et al., 1990). Importantly, and in line 
with the Danish Qualitative Model (regulated by the Danish Mental Health System), a panel of 
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psychiatrists and health professionals (nurses and psychologists) confirm all diagnoses in a 
conference session. Within the forensic system in Denmark, diagnoses are subject to a thorough 
evaluation given the legal implication of the diagnosis for the accused offender and the decision 
of the court. Hence, it is highly unlikely that our sample included malingerers.  
 
All patients were stabilized on fixed doses of anti-psychotic medications. None suffered an 
organic brain disorder, was under the influence of alcohol or drugs, or showed signs of being 
under the influence of psychotic symptoms at the time of the interview for the assessment of 
psychopathy and metacognitive abilities. All patients were informed about the nature of the 
study, and were given written summary of the purposes and procedures of the study. The study 
was approved by the Danish Ethical Committee and complies with the requirements of the 
Declaration of Helsinki.  
 
Clinical and demographic measures 
The clinical and demographic data were collected using translated and validated Danish 
measures and included a socio-demographic questionnaire, the vocabulary subtest of the 
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III) (Wechsler, 1997), the Global 
Assessment of Functioning Scale (GAF), and the abbreviated version of the Positive and 
Negative Syndrome Scale (PANSS) (Kay, Opler, & Lindenmayer, 1989). All assessments and 
interviews were videotaped and assessed by a trained and experienced clinical psychologist 
(S.B). Collateral information was also gathered and medical records were inspected to 
corroborate the assessments made by the rater. For inter-rater reliability purposes, the video 
recording and collateral information of 25% of all cases were made available to a second 
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specially trained rater who was blind to the study. According to the Fleiss-Guidelines (Fleiss, 
Levin, & Paik, 2003), the inter-rater reliability for all instruments were excellent (ICC, all rs≥ 
0.80, all ps < 0.001). (All subsequent inter-rater reliability measures reported in this study are 
evaluated using the Fleiss-Guidelines).  
 
Assessment of psychopathy 
Psychopathy was assessed using the Hare Psychopathy Checklist-Revised (PCL-R) (Hare, 2003). 
The PCL-R is a clinical construct rating scale that uses a semi-structured interview, file-records 
(including criminal records) and specific scoring criteria to assess whether a person possesses 
psychopathic traits. Specifically, it assesses an individual’s interpersonal, behavioural and 
affective aspects, factorially grouped into two factors: Factor 1 relates to the emotional and the 
interpersonal aspects of psychopathy (e.g., deception, deceitfulness, lack of remorse or guilt), 
and Factor 2 relates to the behavioral aspect (e.g., impulsivity, irresponsibility). The PCL-R 
consists of 20 items on a 3-point scale (0, 1, 2). The total score ranges from 0-40 and reflects the 
extent to which a person matches the prototypical psychopath.   
The interview was videotaped. The video recordings of the interview and the collateral 
information used for the assessment of 25% of the cases were made available to a second rater 
who was blind to the purposes of the study. The inter-rater reliability agreement was excellent 
(ICC, r=.87, p<0.001). It is important to note that naïve raters may face difficulties in 
distinguishing between schizophrenia symptoms and psychopathy traits. For example, there can 
be confusion between schizophrenia negative symptoms and diminished affectivity in 
psychopathy. However, we guarded against these pitfalls, as both raters in our study are certified 
raters (educated by Adele Forth and certified by the Robert Hare Lab) with significant 
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experience in administering and scoring the PCL-R including in patients with schizophrenia as 
well as patients with personality disorders. Such confusions would be expected to result in 
significant associations between the PCL-R and the patients’ schizophrenia symptoms. This is 
not the case here as the PCL-R scores were not associated with either the positive (r=.06, p=.62) 
or the negative (r=-.08; p=.48) symptoms. 
 
Metacognition  
The patients’ metacognitive abilities were assessed using the Metacognition Assessment Scale-
Abbreviated Version (MAS-A) (Lysaker et al., 2005), which was specifically developed to 
measure these abilities in patients with serious mental diseases such as schizophrenia. This scale 
is an adaptation of the MAS by Semerari et al. (Semerari et al., 2003) which was originally 
designed to detect changes in these abilities in patients with personality disorders undergoing 
psychotherapy. Typically, the MAS-A utilizes a conversational paradigm (Lysaker, Clements, 
Plascak-Hallberg, Knipscheer, & Wright, 2002) with the objective to provide a more naturalistic 
method to evaluate the use of metacognitive abilities as opposed to scripted, laboratory-based 
paradigms in which these abilities are cued. Specifically, during the interviews used for the 
purposes of this study, the interviewer discussed with the patient a number of topics such as 
employment history, career goals, upbringing and family history, friends and intimate relations 
and antisocial behavior. For example, patients recounted in an interactive way with the 
interviewer their school history, whether they liked their school period, how their teachers would 
have described them, and how they interpreted their own role in the peer group. Similarly, a 
discussion of antisocial behavior offers a rich context during which patients can demonstrate the 
use or lack thereof of complex metacognitive abilities, as well as to examine how they reflect on 
 11 
their antisocial behaviors. Thus, there are a number of opportunities throughout the interview for 
the patient to demonstrate the ability to think about their own mental states, the mental states of 
others, as well as the ability to dealing with certain challenges.  
 
As all interviews are videotaped, another important advantage of this procedure is that it allows 
the rater to take into account valuable information conveyed through gesture and facial 
expressions when coding the these abilities. Gestures (as in pointing to oneself or another) can be 
helpful in ascertaining whether the patient understands and appropriately represents certain 
mental states such as intentionality. Similarly, facial expressions can mirror certain affective 
mental states such as those referring to anger and sadness, and thus a mismatch may indicate a 
failure to relate to these emotions.  
 
The validity of the MAS-A has been demonstrated in studies showing that patients with 
schizophrenia scored more poorly than individuals with a serious and chronic, non-psychiatric, 
medical illness (Lysaker et al., 2012) and adults with substance use disorders but no history of a 
diagnosis of psychosis (Lysaker, Leonhardt, Brune, et al., 2014). In addition, studies demonstrate 
that the scores on the MAS-A are associated with illness insight (Kukla, Lysaker, & Salyers, 
2013), tests of self-awareness (Lysaker, Dimaggio, Carcione, et al., 2010) as well as of social 
cognition (Lysaker, Dimaggio, Daroyanni, et al., 2010). The MAS-A has also been used to assess 
metacognition in patients with schizophrenia in whom psychopathy levels were assessed using 
the PCL-R (Bo et al., 2014). To the authors knowledge, no studies have used the MAS-A in 
healthy individuals (See Lysaker and colleagues (Lysaker, Leonhardt, Pijnenborg, et al., 2014) 
for a recent review of studies utilizing the MAS-A).  
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The MAS-A consists of four subscales: Self-Reflectivity (or MAS-A-Self) is a 9-point likert scale 
which assesses the comprehension of one's own mental states and use of these mental states to 
form complex ideas about oneself; Awareness of the mind of the other (or MAS-A-Other) is a 7-
point likert scale that assesses the comprehension of mental states of other individuals and the 
integration of this understanding in an increasingly complex and coherent manner; Decentration 
(or MAS-A-Decentration) is a 3-point likert scale which assesses the ability to see that others can 
have independent motives and unique perspectives on life events; and Mastery (or MAS-A-
Mastery) is a 9-point likert scale which assesses the ability to use one’s own mental states to 
implement effective action strategies to deal with psychological and social dilemmas.  
 
This four-subscale structure of MAS-A diverged from the original structure of the MAS 
(Semerari et al., 2003) which consisted of only of the Self-Reflectivity, Awareness of the mind 
of the other, and Mastery subscales. Importantly, the use of the 3-point Decentration subscale has 
been problematic, as it tends to produce skewed distribution not appropriate for correlational 
analyses (Lysaker et al., 2005; Lysaker et al., 2008). Specifically, it has been noted that about 
75% of the schizophrenia patients tend to score 1 or below 1 on this subscale (Lysaker et al., 
2008)—in our sample, 71% of the participants scored 1 or below 1 on this subscale. Due to the 
problematic properties of this subscale, there is precedence from the authors of the MAS-A to 
exclude the Decentration subscale from analyses (Lysaker, Dimaggio, Daroyanni, et al., 2010). 
In addition, in our data, the Decentration subscale scores correlated negatively and significantly 
(p<.05) with the scores on the other (r=-.37) and the mastery (r=-.32) subscales and 
nonsignificantly with the self subscale (r=-.23) and the MAS-A-Total (r=-.18), further 
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highlighting the problematic nature of this subscale, and the interpretability of findings 
associated with it. Given these considerations, the Decentration subscale is not considered in this 
study. Specifically, we conduct our analyses on the scores obtained on the Self (9-points), Other 
(7-points) and Mastery (9-points) subscales, as well as on the combined scores of these subscales 
(MAS-A-Total), as a measure of the patients’ overall metacognitive abilities.   
Each subscale is scored in a hierarchical order, with higher levels (or steps) demonstrating that 
the individual is able to think about oneself and other’s knowledge, intentions and emotions in an 
increasingly complex and integrated manner. Failing at lower steps suggests that the individual 
may not be capable of passing higher ones. For example, it should not be possible to understand 
links between one’s thoughts and one’s feelings, if the individual has difficulties in recognizing 
his or her emotions. A point is awarded for passing each step. A half point can be awarded if the 
individual demonstrates inconsistent appropriate use of certain abilities such as the use of 
emotions in particular instances/topics and failure to do so in others (See Supplementary 
Information for detailed description of the various steps associated with each of the subscales 
and the scoring procedure).  
 
The same raters assessing the PCL-R also assessed the MAS-A. Crucially, the second rater who 
was blind to the purposes of this study assessed 25% of the cases and was also blind to the PCL-
R scores of these cases. The inter-rater reliability for this scale was excellent (ICC, r=0.83 (p< 
0.001).  
 
Results 
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To estimate the relationship between the patients’ scores on the MAS-A and the PCL-R, we first 
conducted a correlation analysis between the MAS-A-Total scores and the various clinical and 
demographic variables (Table 1). The results indicated significant negative associations with the 
PCLR-R scores and positive symptoms, and positive associations with intelligence and social 
functioning (GAF). In addition, the female patients scored significantly higher than the male 
patients on both the MAS-A-Total (Mean difference=2.01; tdf=77=2.17; p=.033; Cohen’s d=.57) 
and the MAS-A-Mastery (Mean difference =1.11; tdf=77=2.63; p=.010; Cohen’s d=.82).  
 
Table 1 about here 
 
We thus first fitted a simple linear regression to estimate the MAS-A-Total scores as a function 
of the PCL-R scores using Generalized Linear Models, controlling for gender, intelligence, 
positive symptoms and social functioning. We obtained an overall significant model (X2=92.25, 
df=5, p<.001). As can be seen from Figure 1A, there is a significant negative association 
between the metacognition scores and psychopathy  (β(SE)=-0.28(0.03); 95% CI=-0.33, -0.23), 
p<.001). However, the residuals plot (Figure 1B) revealed a curvilinear trend (β(SE)=0.53(0.18; 
t=3.02, p=.003), confirming the curvilinearity one can observe from a visual inspection of the 
data presented in Figure 1A. This suggests that fitting a linear regression runs the risk of 
misrepresenting the association between these two factors. 
 
Figure 1 about here 
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We therefore fitted a piece-wise regression model where we regressed the PCL-R scores against 
the standardized adjusted MAS-A-Total scores to account for the confounding effects of gender, 
intelligence, social functioning and positive symptoms. Piecewise regression, also known as 
segmented linear regression, is a method used to quantify an abrupt change in the nature of the 
association between the dependent and independent variables. In this type of analysis, the 
independent variable is sectioned into segments. Each segment is then fitted a separate regression 
line. These segments are separated by a breakpoint or a threshold value, beyond which the nature 
of the association between the dependent and independent variable changes (Abu-Akel, Bailey, 
& Thum, 2004; Thum & Bhattacharya, 2001). This approach has the advantage of not only 
estimating the nonlinearity in the data but also allows us to detect a potential change point in the 
data, that is, where a change in the magnitude or direction of the association between 
psychopathy and metacognitive abilities might be present. Importantly, our model assumed an 
unknown breakpoint (θ) at which the association between metacognition and psychopathy 
changes. We utilize the bootstrap method to estimate the confidence intervals of the regression 
coefficient for each segment as well as the breakpoint in the data. The bootstrap method is an 
alternative to parametric methods when the assumptions of those methods are in doubt, or where 
parametric inference is impossible (Davison & Hinkley, 2006). Specifically, the bootstrap 
method repeatedly samples from the original data with replacement and calculates the statistics 
of interest for each generated sample. The confidence interval is calculated from the resulting 
variation of the statistics. In our application of the bootstrap method, the statistics is calculated 
by the constrained nonlinear regression algorithm (CNLR; (IBM, 2011)), such that for each 
generated sample the CLNR determines the parameters (statistics) of the piecewise linear 
regression. For our model, we report the parameter estimates and their confidence intervals (CI) 
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based on the results of 100 bootstrap samples. The analysis yielded a significant model 
(F(4,75)=5.98, p<.001, Cohen’s d=1.30). The model estimated a breakpoint corresponding to 24 
on the PCL-R scale (SE= .99; Bootstrap 95% CI= 22.04, 25.96) (see Figure 2), observing a 
significant negative association between the metacognition and psychopathy scores prior the 
breakpoint (β(SE)=-0.10(0.03); Bootstrap 95% CI= -0.17,  -0.03), and a significant positive 
association post the breakpoint (β(SE)=0.37(0.10); Bootstrap 95% CI= 0.17, 0.58).  
 
Figure 2 about here 
 
Using this change point, we divided the sample into two groups. One group consisted of 
individuals scoring 24 or less on the PCL-R (N=48) and the other consisted of individuals 
scoring above 24 on the PCLR-R (N=31). There were no differences on any of the demographic 
or clinical variables between the groups. However, the group with extreme psychopathy scored 
significantly higher on the adjusted MAS-A-Total scores (F(1,77)=4.29, df=1, p=.042, Cohen’s 
d=.47). This effect size means that about 69% of the high psychopathy group scored above the 
mean of the adjusted MAS-A-Total scores of the low psychopathy group.  
 
However, given the multicomponent nature of metacognitive abilities, the observed association 
between psychopathy and MAS-A might be driven by a more nuanced aspect of metacognition. 
We thus ran the analyses, both linear (using Generalized Linear Models) and piece-wise 
regression (as detailed above) on the adjusted scores of the self, other and mastery subscales of 
the MAS-A after controlling for potential confounds as revealed by correlational analyses with 
the various demographic and clinical measures (see Table 1).  
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First, we ran a linear regression model examining the association between the PCL-R scores and 
the MAS-A-Self subscale, while controlling for the WAIS vocabulary scores. The model was 
significant (X2=56.88, df=2, p<.001), revealing a significant negative association between the 
two measures (β(SE)=-0.08(0.01); 95% CI=-0.10, -0.06), p<.001). The piece-wise regression 
model was also significant (F(4,75)=3.09, p=.021, Cohen’s d=.81). Specifically, it revealed that 
the negative association between the two measures (β(SE)=-0.04(0.02); Bootstrap 95% CI= -
0.07,  -0.002) is arrested at a score corresponding to 25 on the PCL-R (SE= 1.29 Bootstrap 95% 
CI= 22.44, 27.56), which then becomes positive in individuals scoring above 25 on the PCL-R 
(β(SE)=0.18(0.08); Bootstrap 95% CI= 0.03,  0.33).  
 
Second, we ran a linear regression model examining the association between the PCL-R and 
MAS-A-Other scores, while controlling for GAF, PANSS positive symptoms and WAIS 
vocabulary. The model was significant (X2=74.94, df=4, p<.001), revealing a negative 
association between the two measures (β(SE)=-0.11(0.01); 95% CI=-0.13, -0.08). Here, too, the 
piece-wise regression model was significant (F(4,75)=5.74, p<.001, Cohen’s d=1.09). It revealed 
that this negative association (β(SE)=-0.05(0.02); Bootstrap 95% CI= -0.08,  -0.02) is arrested at 
a score corresponding to 24.96 on the PCL-R (SE= 1.44 Bootstrap 95% CI= 22.11, 27.82), which 
then becomes positive in individuals scoring above 24.96 on the PCL-R (β(SE)=0.23(0.09); 
Bootstrap 95% CI= 0.06, 0.40). 
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Finally, the linear regression examining the association between the PCL-R scores and the MAS-
A-Mastery subscale, controlling for gender, positive symptoms, GAF and WAIS vocabulary was 
significant (X2=38.87, df=5, p<.001), revealing a significant negative association between the 
two measures (β(SE)=-0.09(0.02); 95% CI=-0.12, -0.05), p<.001). Here, however, the piece-wise 
regression model was non-significant (F(4,75)=1.07, p=.38; Cohen’s d=.33).  
 
Discussion 
In this paper, we examined the association of metacognitive abilities with psychopathy in 
forensic patients with schizophrenia. A key finding of our study is that the decline in the 
patients’ overall metacognitive abilities was arrested at extreme levels of psychopathy. 
Interestingly, this shift occurred within the range of the cut-off point used for the diagnosis of 
psychopathy in Europe, which corresponds to a score of 26 on the PCL-R. Moreover, the better 
overall metacognitive abilities of the patients with extreme levels of psychopathy (Cohen’s d = 
.47) suggest that these patients may constitute a specific group in which schizophrenia has an 
attenuated impairing effect on metacognition. Furthermore, the lack of difference between the 
low and high psychopathy groups on any of the demographic and clinical measures suggests that 
comorbid psychopathy in schizophrenia is intrinsically associated with functioning 
metacognitive abilities. This constitutes a profile that is consistent with the ability of these 
patients to commit premeditated and goal directed acts of violence (Abu-Akel & Abushua'leh, 
2004; Bo et al., 2011; Rice, 1997), as well as with findings showing that psychopathic offenders 
are more instrumental than non-psychopaths in committing their acts of violence (Woodworth & 
Porter, 2002). Taken together, our findings thus offer important insights to understanding a group 
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of patients that hitherto has been dubbed “unrecognized subtype of schizophrenia” (Volavka & 
Citrome, 2008). 
 
However, our analyses pertaining to the association of the PCL-R with the MAS-A subscales, 
show that the attenuating effect of high psychopathy scores on metacognitive difficulties was 
detected in all subscales, except for the Mastery domain of the MAS-A, whereby higher PCL-R 
scores were increasingly associated with more difficulties in the ability to use one’s own mental 
states to implement effective action strategies to deal with psychological and social dilemmas. 
While, to the authors’ knowledge, there are no studies to date that used the MAS-A in healthy 
controls, the mean score on this subscale in the patients scoring above 24 on the PCL-R in our 
sample was lower than individuals with serious and chronic, non-psychiatric, medical illness 
(Mean difference=2.91 which is about 1.5 SD below the mean) (Lysaker et al., 2012), as well as 
adults with substance use disorders but no history of a diagnosis of psychosis (Mean differences 
=1.19 which is about 1 SD below the mean) (Lysaker, Leonhardt, Brune, et al., 2014). Taken 
together, these analyses suggest that the attenuating effect of high levels of psychopathy traits 
and metacognition are primarily driven by metacognitive domains reflective of the ability to 
understand self and other mental states. Accordingly, we hypothesize that schizophrenia patients 
with high psychopathy levels will demonstrate better overall theory of mind abilities. 
 
Several proposals suggest that psychosocial treatments may be effective in reducing the 
propensity of schizophrenia patients for violence (Volavka & Citrome, 2011). There is also 
evidence showing that psychosocial abilities such as empathizing and understanding the 
perspective others are associated with reduced violence and aggression (Abu-Akel & 
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Abushua'leh, 2004; Flight & Forth, 2007; Woodworth & Porter, 2002). Therefore, the current 
findings may have implication for treatment interventions among the schizophrenia patients with 
high level or co-morbid psychopathy. Specifically, we suggest that adjunctive treatment that are 
specifically targeted at enhancing the capacity of the Mastery domain in patients with high levels 
of psychopathy may be effective in the recognition of and dealing with psychological and social 
challenges and dilemmas that lead to frustration and offending behavior. This suggestion finds 
support in research reporting that metacognitive mastery (as assessed by the MAS-A) is 
predictive of the ability to cope with stressors, having greater insight and higher levels of feeling 
accepted by peers (Lysaker et al., 2011), as well as of intrinsic motivation, i.e., the propensity to 
pursue novel experiences and to take part in active self-improvement (Vohs & Lysaker, 2014). 
There is also promising evidence from rich case studies and open trials suggesting that 
metacognitive therapy can improve overall functioning in patients with schizophrenia (Van 
Donkersgoed et al., 2014). The consideration of such interventions are especially important in 
light of research showing that pharmacotherapeutic interventions appear to have little effect on 
reducing the propensity of these patients for violence (Nolan et al., 1999; Swanson et al., 2008).  
 
Methodologically, our analytical approach clearly demonstrates that standard linear regression 
analyses can yield underspecified explanatory models, and thus we highlight the importance of 
examining non-linear relationships within the context of complex disorders such as 
schizophrenia. Importantly, however, future research would need to determine the specificity of 
the observed non-linear association between psychopathy levels and metacognition in these 
patients. For example, it is unknown whether this association would also be found in measures of 
executive function. However, when investigating the association of WAIS vocabulary scores 
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with psychopathy, the piece-wise regression model was non-significant (F(4,75)=1.09, p=.37). 
Tentatively, this thus suggests that the non-linear association between psychopathy and 
metacognition may not be generalizable to other (non-social) cognitive abilities. 
 
In summary, our analyses show that while patients tended to show declining metacognitive 
abilities with increasing levels of psychopathy, the decline was arrested at extreme levels of 
psychopathy—occurring within the range of the cut-off point used for the diagnosis of 
psychopathy. While the relatively small sample of our study prevents us from drawing strong 
conclusions, the moderate to large effect sizes observed suggest that our findings have practical 
significance. Moreover, it is noteworthy that the relative preservation of metacognitive abilities 
in schizophrenia patients with high levels of psychopathy is consistent with their ability to 
commit premeditated and goal directed acts of violence. However, as pointed above, the absence 
of this effect on the Mastery domain suggests that psychosocial treatments that specifically target 
this domain in schizophrenia patients with comorbid or high levels psychopathy may prove 
effective in reducing their propensity for violence and offending. Accordingly, there is an 
obvious need for research to assess the utility of such interventions in this population, and 
particularly to examine under what conditions may such treatments prove effective. Moreover, 
given the lack of information on type of offenses committed by our patients, it would be 
intriguing to examine, in future research, whether the non-linear association between 
metacognition and psychopathy pertains equally to individuals who predominantly commit 
impulsive versus premeditated type of offenses. Comparing schizophrenia patients with and 
without psychopathy, using various research paradigms (of neurocognition, social cognition and 
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metacognition), is a critical further step to understanding the mechanisms involved in countering 
the deterioration of metacognitive abilities in schizophrenia patients with comorbid psychopathy.  
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Table/Figure Legends 
Table 1. Socio-demographic, clinical and cognitive characteristics of the schizophrenia patients 
and their correlation with the MAS-A and subscales 
 
Figure 1. Figure 1A depicts the negative association between overall psychopathy and the total 
Metacognitive Assessment Scale-Abbreviated (MAS-A) scores. Figure 1B suggests that linear 
regression may be a misrepresentation of the depicted association in Figure 1A. 
 
Figure 2. Piece-wise regression as a function of the adjusted standardized scores of the total 
Metacognitive Assessment Scale-Abbreviated (MAS-A) and the Psychopathy Checklist Revised 
(PCL-R) scores. θ=24 indicates the change point where the association between the scores shifts 
from negative to positive. 
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Table 1. Socio-demographic, clinical and cognitive characteristics of the schizophrenia patients 
and their correlation with the MAS-A and subscales 
 
Variable 
Schizophrenia 
Sample (N=79) 
Correlations with MAS-A Total and subscales† 
MAS-A-  
Total 
MAS-A- 
Self 
MAS-A- 
Other 
MAS-A- 
Mastery 
Gender (M, F) †† 15, 64 -- -- -- -- 
Age (years) 36.86±10.37 .01 -.003 -.03 .08 
Duration of Illness 
(months) 
97.60±72.09 -.01 -.01 .08 .12 
WAIS (Vocabulary) 8.73±1.97 .39** .40** .33** .24* 
PANSS Negative 5.61±2.80 -.03 -.08 -.01 -.07 
PANSS Positive 5.71±2.99 -.29** -.21 -.26* -.28* 
GAF 41.54±6.69 .33** .19 .23* .39** 
PCL-R Total 20.58±8.74 -.65** -.55** -.63** -.51** 
MAS-A Total 11.66±3.16 -- .81** .77** .79** 
MAS-A-Self 3.99±1.16 -- -- .67** .50** 
MAS-A-Other 4.42±1.18 -- -- -- .37** 
MAS-A-Mastery 3.23±1.53 -- -- -- -- 
*p<.05. **p<.01 
† Correlations are Spearman’s rho. †† Female patients scored higher than male patients on the MAS-
A-Total and the MAS-A-Mastery (see text). 
WAIS= Wechsler Adult Intelligence Scale; GAF= Global Assessment of Functioning; PANSS= 
Positive and Negative Syndrome Scale (PANSS); PCL-R= Psychopathy Checklist-Revised; 
MAS-A= Metacognitive Assessment Scale-Abbreviated. 
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Figure 1. Figure 1A depicts the negative association between overall psychopathy and the total 
Metacognitive Assessment Scale-Abbreviated (MAS-A) scores. Figure 1B suggests that linear 
regression may be a misrepresentation of the depicted association in Figure 1A. 
 
 
 
 
 
 
 
 
 
 29 
 
Figure 2. Piece-wise regression as a function of the adjusted standardized scores of the total 
Metacognitive Assessment Scale-Abbreviated (MAS-A) and the Psychopathy Checklist Revised 
(PCL-R) scores. θ=24 indicates the change point where the association between the scores shifts 
from negative to positive. 
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